BioAtla Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-123.46	-106.48	-95.4	-35.85	-29.79	-28.98
Depreciation & Amortization	1.22	1.2	1.33	1.01	0.86	0.79
Share-Based Compensation	13.54	14.56	25.12	3.02	0	0
Other Operating Activities	4.68	0.3	6.74	-4.51	19.29	-7.13
Operating Cash Flow	-104.02	-90.42	-62.21	-36.33	-9.65	-35.32
Capital Expenditures	-0.1	-0.27	-0.92	-0.59	-1.51	-0.99
Investing Cash Flow	-0.1	-0.27	-0.92	-0.59	-1.51	-0.99
Share Issuance / Repurchase	0.34	61.97	69.51	200.23	0	0
Debt Issued / Paid	0	0	0	3.43	4	5
Other Financing Activities	-0.26	-0.76	-	68.16	-0.01	0.02
Financing Cash Flow	0.08	61.21	69.51	271.83	4	5.02
Net Cash Flow	-104.04	-29.47	6.37	234.9	-7.16	-31.29
Free Cash Flow	-104.11	-90.69	-63.14	-36.92	-11.15	-36.31
Free Cash Flow Margin	-	-	-25255.20%	-8606.99%	-214.50%	-341.63%
Free Cash Flow Per Share	-2.18	-2.33	-1.83	-4.38	-0.20	-0.67

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).